investigated the GSH-triggered release of tyrosine kinase inhibitor anticancer drug Sunitinib encapsulated in biocompatible degradable polyglycerol-SS-polyester micelles as represented in Fig
It is indicated as a supportive treatment for liver disease as well as for the treatment of hepatitis, acetonuria, hypocalcaemia, paresis, milk fever, intoxication, ketosis, lumbago, tetany, puerperal diseases, and metabolic disorders
There are two types of GHS studied in the scientific literature: peptide GHS and non-peptide compounds
Terawaki H, Murase T, Nakajima A, et al
Patients not only experience more weight loss but also improved satiety and fewer cravings
In some cases, individuals may experience allergic reactions or sensitivities to glutathione supplements